Damage-Associated Molecular Patterns (DAMPs) are endogenous danger signals released when cells die badly or are mechanically damaged, alerting the innate immunity system to tissue injury. Unlike PAMPs (which signal "foreign invader"), DAMPs signal "internal catastrophe" β they are normally sequestered molecules (intracellular or extracellular matrix fragments) that become immunogenic when exposed to the extracellular environment. Major DAMPs include ATP, HMGB1, Uric acid, Heat shock proteins, hyaluronan fragments, and cell-free mitochondrial DNA (mtDAMPs).
Think of DAMPs like a building's internal alarm system that only triggers when walls are physically breached. Normally, certain "vault materials" are locked inside cells or embedded in structural concrete (the extracellular matrix): ATP is locked in cellular batteries, HMGB1 is wrapped around DNA in the nucleus, uric acid crystals are kept dissolved in solution, and hyaluronan is woven into structural cables. When an earthquake (mechanical damage), fire (ischemia), or bombing (necrosis) destroys the building, these vault materials spill into the street. Passersby (immune cells and sensory neurons) recognize these materials as alarm signals β "this building is collapsing, send emergency crews!"
In the gut, epithelial cells are like townhouses lining a river (the gut lumen). When Leaky gut occurs β whether from inflammation, toxins, or food-derived damage β these houses collapse, spilling their contents into both the street (lamina propria) and the river (gut lumen). The immune system can't tell why the houses fell, only that they did fall β and it responds with full emergency protocols. If bacteria simultaneously breach the barrier (bacterial translocation), it's like looters entering through the rubble: now you have DAMPs plus PAMPs, and the inflammatory response goes nuclear. This dual-danger scenario drives chronic gut inflammation in IBS, IBD, and metabolic endotoxemia.
DAMPs are released through three main routes:
- Necrotic cell death (passive release)
- Mechanical damage to extracellular matrix
- Active secretion during cellular stress (e.g., ATP release via pannexin channels during hypoxia)
ΒΆ Major DAMPs and Their Receptors
Intracellular DAMPs:
- ATP: Released via pannexin-1 channels or membrane rupture β binds P2X3 Receptor, P2X7, P2Y receptors β calcium influx β NLRP3 inflammasome activation β caspase-1 β IL-1Ξ² and IL-18 maturation
- HMGB1 (High Mobility Group Box 1): Nuclear DNA-binding protein released from necrotic cells or actively secreted by immune cells β binds TLR4, TLR2, RAGE (receptor for advanced glycation end-products) β NF-ΞΊB activation β pro-inflammatory cytokine transcription (TNF-Ξ±, IL-6, IL-1Ξ²)
- Uric acid crystals: Product of purine metabolism, crystallizes when cells lyse β phagocytosed by macrophages β lysosomal damage β NLRP3 inflammasome β IL-1Ξ²
- Heat shock proteins (HSP60, HSP70, HSP90): Molecular chaperones released during stress β bind TLR4, TLR2, CD91 β NF-ΞΊB and MAPK activation
- Cell-free mtDNA: Contains unmethylated CpG motifs (bacterial signature) β binds TLR9, cGAS-STING pathway β type I interferons β antiviral-like inflammatory response
Extracellular Matrix DAMPs:
- Hyaluronan fragments (low molecular weight): Matrix degradation products β bind TLR4, TLR2, CD44 β NF-ΞΊB activation
- Fibronectin fragments: Matrix breakdown β bind TLR4 β pro-inflammatory macrophage activation
- Heparan sulfate fragments: Glycosaminoglycan breakdown β bind TLR4 β dendritic cell maturation
In the intestinal epithelium:
- Barrier damage (tight junction disruption, apoptosis, necrosis) β DAMP release into lamina propria
- DAMPs bind pattern recognition receptors on:
- ATP additionally activates:
When barrier dysfunction allows bacterial translocation:
- DAMPs + PAMPs (e.g., LPS) β synergistic TLR4 activation
- Priming effect: DAMPs sensitize immune cells to lower PAMP thresholds
- HMGB1 acts as a carrier protein for LPS β 100-1000x potentiation of TLR4 signaling
- Result: Low-grade endotoxemia becomes high-grade inflammation
graph TD
A[Epithelial Damage] --> B[DAMP Release]
B --> C[ATP]
B --> D[HMGB1]
B --> E[Uric Acid Crystals]
B --> F[Matrix Fragments]
C --> G[P2X7 Receptor]
C --> H[TRPV1/TRPA1]
D --> I[TLR4]
E --> J[NLRP3 Inflammasome]
F --> I
G --> K[NLRP3 Activation]
H --> L[Nociceptor Sensitization]
I --> M["NF-ΞΊB Activation"]
J --> K
K --> N["IL-1Ξ²/IL-18"]
L --> O[Visceral Pain]
M --> P["TNF-Ξ±, IL-6"]
N --> Q[Systemic Inflammation]
P --> Q
R[Bacterial Translocation] --> S[LPS/PAMPs]
S --> I
D -.HMGB1-LPS complex.-> I
I -.Synergy.-> T[Amplified Inflammation]
style A fill:#ff6b6b
style Q fill:#ee5a6f
style T fill:#c44569
DAMPs are the mechanistic link between tissue damage and inflammation β critical for understanding chronic inflammatory conditions where no pathogen is present. This violates the classical "infection β inflammation" model and explains sterile inflammatory syndromes.
Gut Dysfunction:
- IBS (post-infectious and non-infectious types): Elevated fecal ATP, HMGB1, and calprotectin correlate with symptom severity. DAMPs explain why IBS patients have visceral pain without active infection β epithelial turnover stress, food-induced damage, and bile acid toxicity release DAMPs that sensitize TRPV1 on mesenteric afferents.
- IBD (Crohn's, ulcerative colitis): Chronic epithelial damage β continuous DAMP release β sustained TLR4/NLRP3 activation β pro-inflammatory macrophage polarization. Mucosal HMGB1 levels correlate with disease activity scores.
- Leaky gut/intestinal permeability: Tight junction disruption allows apoptotic epithelial cells to release DAMPs before bacteria translocate β this is the "first hit" that primes the immune system. When LPS follows (second hit), inflammation escalates.
Metabolic Disorders:
- Metabolic endotoxemia (obesity, Type 2 Diabetes): Adipocyte death β DAMP release β Metaflammation. Uric acid crystals (from fructose metabolism) activate NLRP3 in visceral fat β IL-1Ξ² β Insulin resistance.
- NAFLD/NASH: Hepatocyte lipotoxicity β mitochondrial DAMPs β TLR9 activation β stellate cell activation β fibrosis.
Pain Syndromes:
- Visceral Hypersensitivity: ATP directly activates P2X3/P2X7 on mesenteric afferents β calcium influx β action potential firing. HMGB1 sensitizes TRPV1, lowering nociceptor activation threshold. This explains why IBS pain persists even after infection resolves β tissue repair releases DAMPs that maintain sensitization.
- Fibromyalgia, Chronic fatigue syndrome: Muscle microtrauma β ATP release β metaboreceptor sensitization. Elevated serum HMGB1 in CFS patients suggests systemic DAMP-driven inflammation.
DAMPs represent the immune system's damage detection override β it doesn't wait for infection confirmation, it responds to structural integrity loss. This is evolutionarily adaptive (rapid wound response) but maladaptive in chronic low-grade damage scenarios (modern diet, sedentarism, sleep deprivation). The Selfish Immune System prioritizes inflammation over metabolic efficiency when DAMPs are chronically elevated.
-
Reduce DAMP generation:
- Restore barrier function: L-glutamine (5-15 g/day), Zinc (30-50 mg/day), Vitamin D (target 40-60 ng/mL)
- Antioxidants to prevent necrosis: Quercetin (500-1000 mg/day), Curcumin (1000-1500 mg/day)
- Heat therapy (Sauna): Upregulates HSP70 before damage occurs β cytoprotection β less necrotic DAMP release
-
Block DAMP receptors:
- TLR4 antagonists: Experimental (not clinically available), but dietary polyphenols (EGCG, resveratrol) provide weak TLR4 inhibition
- P2X7 antagonists: Brilliant blue G (experimental), ATP-degrading enzymes (apyrase)
-
Enhance DAMP clearance:
- Efferocytosis support: Omega-3 fatty acids (EPA/DHA 2-4 g/day) β resolvins β macrophage clearance of apoptotic cells before secondary necrosis
- Uric acid management: Allopurinol (gout), low-purine diet, hydration
-
Metabolic interventions:
- Ketogenic diet: Ξ²-hydroxybutyrate inhibits NLRP3 inflammasome β reduces IL-1Ξ² response to uric acid and ATP
- Intermittent fasting: Reduces cellular stress β fewer DAMPs from baseline metabolic activity
- Serum HMGB1 >5 ng/mL: Associated with systemic inflammation, sepsis risk, autoimmune flares (research range, not standard clinical test yet)
- Fecal Calprotectin >50 ΞΌg/g: Indirect DAMP marker (neutrophil activation) β indicates mucosal damage releasing DAMPs
- Plasma cell-free mtDNA >3500 copies/ΞΌL: Elevated in trauma, sepsis, autoimmune disease β direct DAMP biomarker
- DAMPs signal "sterile inflammation" β tissue damage without infection
- Released by necrosis, mechanical damage, or active secretion during cellular stress
- Major DAMPs: ATP, HMGB1, Uric acid, Heat shock proteins, hyaluronan fragments, cell-free mtDNA
- Primary receptors: TLR4, TLR2, TLR9, NLRP3 inflammasome, TRPV1, TRPA1, P2X/P2Y receptors
- ATP activates P2X3 Receptor (nociceptors) at concentrations >10 ΞΌM β gut damage easily exceeds this threshold
- HMGB1 potentiates LPS signaling by 100-1000x when complexed together
- Uric acid >6.8 mg/dL (supersaturation point) β crystal formation β NLRP3 activation β Gout, metabolic inflammation
- DAMPs directly sensitize TRPV1 β lowers heat/capsaicin threshold β Visceral Hypersensitivity
- Synergize with PAMPs in Leaky gut β DAMP priming + LPS = amplified inflammation
- Elevated in IBS (fecal ATP, HMGB1), IBD (mucosal HMGB1), NAFLD (hepatic mtDNA), Fibromyalgia (serum HMGB1)
- Heat shock preconditioning (Sauna) upregulates cytoprotective HSPs β reduces necrotic DAMP release
- Ξ²-hydroxybutyrate (ketosis) inhibits NLRP3 β blocks IL-1Ξ² response to DAMPs
- Omega-3 fatty acids enhance efferocytosis β prevent secondary necrosis β reduce DAMP generation
- Fecal Calprotectin >50 ΞΌg/g indirectly reflects mucosal DAMP release (neutrophil activation marker)
- PAMPs β DAMPs synergize with PAMPs in bacterial translocation scenarios; HMGB1-LPS complexes amplify TLR4 signaling 100-1000x
- TLR4 β Primary receptor for HMGB1, hyaluronan fragments, HSPs; links DAMPs to NF-ΞΊB activation
- TLR2 β Recognizes HMGB1, HSPs; triggers pro-inflammatory cytokine production
- TLR9 β Binds cell-free mitochondrial DNA (mtDAMPs) containing unmethylated CpG motifs
- NLRP3 inflammasome β Activated by ATP (via P2X7), uric acid crystals, hyaluronan fragments β IL-1Ξ² maturation
- TRPV1 β Directly activated by ATP, HMGB1, and inflammatory mediators released by DAMPs β nociceptor sensitization
- TRPA1 β Activated by oxidative stress and inflammation triggered by DAMPs β Visceral Hypersensitivity
- P2X3 Receptor β ATP-gated ion channel on nociceptors; mediates visceral pain in gut damage
- Leaky gut β Epithelial barrier dysfunction releases DAMPs before bacterial translocation β primes immune system
- Visceral Hypersensitivity β DAMP-driven nociceptor sensitization explains pain persistence after infection resolves
- Bacterial translocation β DAMPs + PAMPs together drive chronic gut inflammation in IBD, IBS
- IBS β Elevated fecal ATP and HMGB1 correlate with symptom severity; DAMPs explain non-infectious pain
- IBD β Chronic epithelial damage β continuous DAMP release β sustained pro-inflammatory macrophage activation
- ATP β Prototypic DAMP; released by necrosis, hypoxia, mechanical stress; activates inflammasomes and nociceptors
- HMGB1 β Nuclear protein that becomes cytokine-like DAMP when extracellular; potentiates LPS effects
- Uric acid β Product of purine metabolism; crystallizes during cell lysis β NLRP3 activation β Gout, metabolic inflammation
- Heat shock proteins β Cytoprotective when intracellular; immunogenic DAMPs when extracellular; bind TLR4/TLR2
- Intestinal permeability β Tight junction disruption allows DAMP release into lamina propria β immune activation
- Mast cells β Activated by DAMPs (especially ATP) β degranulation β histamine and Substance P release
- NF-ΞΊB β Transcription factor activated by DAMP-receptor signaling β pro-inflammatory cytokine production
- IL-1Ξ² β Matured by NLRP3 inflammasome after DAMP exposure; drives systemic inflammation
- Metaflammation β Adipocyte death in obesity releases DAMPs β chronic low-grade inflammation β Insulin resistance
- Efferocytosis β Macrophage clearance of apoptotic cells; prevents secondary necrosis β reduces DAMP release
- Omega-3 fatty acids β EPA/DHA enhance efferocytosis and produce resolvins β limit DAMP generation
- Sauna β Heat preconditioning upregulates cytoprotective HSPs β prevents necrotic DAMP release during stress
- Ketogenic diet β Ξ²-hydroxybutyrate inhibits NLRP3 inflammasome β reduces IL-1Ξ² response to DAMPs
- Calprotectin β Neutrophil protein released during gut inflammation; indirect marker of mucosal DAMP exposure
- Substance P β Neuropeptide released by DAMP-activated sensory neurons; amplifies neurogenic inflammation